Evommune, Inc. · NYSE:EVMN
Carver Kyle sold 18,175 Evommune, Inc. shares (Form 4)
Traded May 28, 2026 · Filed Jun 1, 2026
On May 28, 2026, Carver Kyle (Chief Financial Officer) sold 18,175 Evommune, Inc. shares at US$22.84 for US$415K under a trading plan, leaving 59,335 shares. Filed Jun 1, 2026 (Form 4).
- Sold
- 18,175 shares
- Price
- US$22.84
- Value
- US$415K
- Holding after
- 59,335 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 28, 2026 | Common Stock | Option exercise | 15,000 | US$2.99 | 77,510 | Direct |
| May 28, 2026 | Common Stock | Sale | 18,175 | US$22.84 | 59,335 | Direct |
Source
Related
- Evommune, Inc.
- Carver Kyle
- Evommune, Inc. shareholders
- Form 4 · Carver Kyle · Jul 10, 2026
- Form 4 · Pena Luis C. · Oct 15, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Andera Partners · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jul 16, 2026
- Form 4 · Kirsch Arthur S · Jul 8, 2026